血清可替代血浆用于化学发光酶免疫法测定ApoE4表型
该研究以157例患者单次采血的血浆和血清为样本,用ApoE4和Pan-ApoE化学发光酶免疫法检测,并以等位基因特异性定量PCR的APOE基因型为参照。结果显示,采用基质特异性阈值时,血浆和血清的ApoE4/Pan-ApoE比值均能准确分类ApoE4表型,且血清与血浆的稳定性和精密度相当,提示血清是可靠的替代样本。
要点
- 血清与血浆的ApoE4/Pan-ApoE比值高度相关,采用基质特异性阈值可准确分类ApoE4表型。
- Lumipulse检测Pan-ApoE和ApoE4的精密度良好,重复性<15%和<5%,中间精密度<10%。
- 血清在4°C至120小时及多次冻融后稳定性与血浆相当,但20°C储存120小时后血清出现劣化。
核心结论
- 采用基质特异性阈值时,血浆和血清的ApoE4/Pan-ApoE比值均能准确分类ApoE4表型,与APOE ε4基因型一致。
- 血清与血浆在稳定性和精密度上相当,血清是使用Lumipulse assays测定Pan-ApoE和ApoE4时可靠的替代样本。
研究设计与样本
- 研究纳入157例患者,单次采血同时获取血浆和血清,用ApoE4和Pan-ApoE化学发光酶免疫法检测。
- 以等位基因特异性定量聚合酶链反应确定的APOE基因型为参照,并额外评估检测重复性、中间精密度及不同储存条件下的样本稳定性。
主要发现
- ApoE4、Pan-ApoE及ApoE4/Pan-ApoE比值在血浆与血清间偏差极小,呈强正相关且线性良好。
- 采用基质特异性阈值时,血浆和血清来源的ApoE4/Pan-ApoE比值分类的ApoE4表型与APOE ε4基因型一致。
- 检测重复性<15%和<5%(第1天和第2天),Pan-ApoE和ApoE4的中间精密度均<10%。
- 血浆和血清在多次冻融后及4°C储存至120小时稳定性相当,而血清在20°C储存120小时后出现劣化。
关键数值与推荐
- 检测重复性<15%和<5%(第1天和第2天),Pan-ApoE和ApoE4的中间精密度<10%。
- 血浆和血清在多次冻融后及4°C储存至120小时稳定性相当,血清在20°C储存120小时后出现劣化。
临床怎么用
- 临床可采用血清替代血浆,使用Lumipulse ApoE4和Pan-ApoE化学发光酶免疫法测定ApoE4表型。
- 结果判读需采用基质特异性阈值,以确保血浆和血清样本分类准确。
- 血清替代可扩大样本可用性,尤其适用于回顾性研究或与脑脊液同时采集的场景。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Since apolipoprotein E4 (ApoE4) is associated with therapy-related adverse effects of anti-amyloid-β monoclonal antibodies in Alzheimer's disease, such as amyloid-related imaging abnormalities, methods for determining the ApoE4 status are needed. The Lumipulse® ApoE4 and Pan-ApoE assays provide a practical approach, but they have so far been validated only in plasma. METHODS: Plasma and serum obtained from a single blood draw from 157 patients were analyzed using ApoE4 and Pan-ApoE chemiluminescent enzyme immunoassays. The APOE genotype was determined by allele-specific quantitative polymerase chain reaction. Additional experiments assessed assay repeatability, intermediate precision, and sample stability under various storage conditions. RESULTS: ApoE4, Pan-ApoE, and the resulting ApoE4/Pan-ApoE ratio showed minimal bias, strong positive correlation and linearity between plasma and serum. Using matrix-specific thresholds, plasma- and serum-derived ApoE4/Pan-ApoE ratios accurately classified the ApoE4 phenotypes in concordance with APOE ε4 genotypes. The assay demonstrated repeatability of <15 % and <5 % (day 1 and 2), with intermediate precision <10 % for both Pan-ApoE and ApoE4. Plasma and serum showed both comparable stability after multiple freeze-thaw-cycles and up to 120 h at 4 °C, while serum showed deterioration after 120 h storage at 20 °C. CONCLUSIONS: Using matrix-specific thresholds, the ApoE4/Pan-ApoE ratio in plasma and serum accurately classified the ApoE4 phenotype in concordance with APOE ε4 genotypes. Serum and plasma showed comparable stability and precision. Thus, serum is a reliable alternative to plasma for measuring Pan-ApoE and ApoE4 with the Lumipulse assays. The use of serum expands sample availability, particularly in retrospective studies or when collected alongside cerebrospinal fluid.
引用
- Kortmann E, Steinacker P, Guthknecht A, et al. Serum as an alternative to plasma for determining the ApoE4 phenotype using Pan-ApoE and ApoE4 chemiluminescent enzyme immunoassays. Clin Chem Lab Med. 2026. PMID: 41842840. doi:10.1515/cclm-2026-0032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。